KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abbott Laboratories (ABT) Non-Current Debt (2016 - 2025)

Historic Non-Current Debt for Abbott Laboratories (ABT) over the last 17 years, with Q3 2025 value amounting to $11.6 billion.

  • Abbott Laboratories' Non-Current Debt fell 958.28% to $11.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $11.6 billion, marking a year-over-year decrease of 958.28%. This contributed to the annual value of $12.6 billion for FY2024, which is 716.23% down from last year.
  • According to the latest figures from Q3 2025, Abbott Laboratories' Non-Current Debt is $11.6 billion, which was down 958.28% from $12.9 billion recorded in Q2 2025.
  • Abbott Laboratories' Non-Current Debt's 5-year high stood at $17.5 billion during Q2 2021, with a 5-year trough of $11.6 billion in Q3 2025.
  • Over the past 5 years, Abbott Laboratories' median Non-Current Debt value was $14.5 billion (recorded in 2022), while the average stood at $14.7 billion.
  • Its Non-Current Debt has fluctuated over the past 5 years, first soared by 407.64% in 2021, then tumbled by 1603.84% in 2022.
  • Quarter analysis of 5 years shows Abbott Laboratories' Non-Current Debt stood at $17.3 billion in 2021, then decreased by 16.04% to $14.5 billion in 2022, then decreased by 6.36% to $13.6 billion in 2023, then decreased by 7.16% to $12.6 billion in 2024, then dropped by 8.15% to $11.6 billion in 2025.
  • Its Non-Current Debt stands at $11.6 billion for Q3 2025, versus $12.9 billion for Q2 2025 and $12.7 billion for Q1 2025.